On the optimal control of SIR model with Erlang-distributed infectious period: isolation strategies.

Bang–bang control Epidemics Erlang distribution Non-exponential distribution Optimal control SIR model

Journal

Journal of mathematical biology
ISSN: 1432-1416
Titre abrégé: J Math Biol
Pays: Germany
ID NLM: 7502105

Informations de publication

Date de publication:
22 09 2021
Historique:
received: 18 03 2021
accepted: 08 09 2021
revised: 22 07 2021
entrez: 22 9 2021
pubmed: 23 9 2021
medline: 27 10 2021
Statut: epublish

Résumé

Mathematical models are formal and simplified representations of the knowledge related to a phenomenon. In classical epidemic models, a major simplification consists in assuming that the infectious period is exponentially distributed, then implying that the chance of recovery is independent on the time since infection. Here, we first attempt to investigate the consequences of relaxing this assumption on the performances of time-variant disease control strategies by using optimal control theory. In the framework of a basic susceptible-infected-removed (SIR) model, an Erlang distribution of the infectious period is considered and optimal isolation strategies are searched for. The objective functional to be minimized takes into account the cost of the isolation efforts per time unit and the sanitary costs due to the incidence of the epidemic outbreak. Applying the Pontryagin's minimum principle, we prove that the optimal control problem admits only bang-bang solutions with at most two switches. In particular, the optimal strategy could be postponing the starting intervention time with respect to the beginning of the outbreak. Finally, by means of numerical simulations, we show how the shape of the optimal solutions is affected by the different distributions of the infectious period, by the relative weight of the two cost components, and by the initial conditions.

Identifiants

pubmed: 34550465
doi: 10.1007/s00285-021-01668-1
pii: 10.1007/s00285-021-01668-1
pmc: PMC8456197
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Phytopathology. 2012 Apr;102(4):365-80
pubmed: 22106830
Sci Rep. 2017 May 24;7(1):2375
pubmed: 28539663
Proc Biol Sci. 2008 Jan 7;275(1630):19-28
pubmed: 17956849
PLoS Comput Biol. 2007 Apr 20;3(4):e71
pubmed: 17447838
Math Biosci. 2016 Jul;277:89-107
pubmed: 27130854
Bull Math Biol. 2017 Sep;79(9):2149-2173
pubmed: 28721471
Science. 2000 Jan 21;287(5452):443-9
pubmed: 10642539
Appl Math Comput. 2016 Jun 20;283:339-354
pubmed: 32287500
Math Biosci. 2017 Oct;292:86-96
pubmed: 28801246
J Math Biol. 1980 Mar;9(1):37-47
pubmed: 7365328
J R Soc Interface. 2013 May 15;10(84):20130098
pubmed: 23676892
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10484-10491
pubmed: 32327608
Am J Epidemiol. 2003 Jul 15;158(2):110-7
pubmed: 12851223
IMA J Math Appl Med Biol. 1997 Mar;14(1):1-9
pubmed: 9080685
Science. 2001 May 11;292(5519):1155-60
pubmed: 11303090
J Math Biol. 2014 Oct;69(4):1001-25
pubmed: 24057080
Trends Ecol Evol. 1995 May;10(5):190-4
pubmed: 21237000
Nature. 1954 Jul 17;174(4420):139-40
pubmed: 13185266
Proc Biol Sci. 2001 May 7;268(1470):985-93
pubmed: 11370974
PLoS Med. 2005 Jul;2(7):e174
pubmed: 16013892
Prev Vet Med. 2003 Mar 20;57(3):155-66
pubmed: 12581598
Proc Biol Sci. 2004 Nov 7;271(1554):2223-32
pubmed: 15539347
Lancet. 1952 Sep 20;2(6734):549-54
pubmed: 12981903
J Math Biol. 2011 Mar;62(3):423-51
pubmed: 20407775
Theor Popul Biol. 2001 Aug;60(1):59-71
pubmed: 11589638
J Infect Dis. 2004 Dec 15;190(12):2088-95
pubmed: 15551206
Bull Math Biol. 2015 Oct;77(10):1909-33
pubmed: 26403422
Math Biosci. 2019 Sep;315:108232
pubmed: 31330135
Bull Math Biol. 2007 Jul;69(5):1511-36
pubmed: 17237913
Epidemics. 2016 Jun;15:10-9
pubmed: 27266845
Acta Biotheor. 2014 Jun;62(2):171-81
pubmed: 24723249
Science. 1997 Jan 3;275(5296):65-7
pubmed: 8974392
Bull Math Biol. 2006 Apr;68(3):679-702
pubmed: 16794950

Auteurs

Luca Bolzoni (L)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Via dei Mercati 13, 43126, Parma, Italy.

Rossella Della Marca (R)

Risk Analysis and Genomic Epidemiology Unit, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Via dei Mercati 13, 43126, Parma, Italy. rossella.dellamarca@izsler.it.

Maria Groppi (M)

Department of Mathematical, Physical and Computer Sciences, University of Parma, Parco Area delle Scienze 53/A, 43124, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH